scholarly journals Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells

1979 ◽  
Vol 181 (3) ◽  
pp. 623-632 ◽  
Author(s):  
B Jasani ◽  
G Kreil ◽  
B F Mackler ◽  
D R Stanworth

Structure-activity studies have been performed on a series of naturally occurring and ‘tailor-made’ polypeptides, by measurement of ability to induce selective histamine release from normal rat peritoneal mast cells in vitro. Compounds investigated include corticotropin and melittin derivatives, mast-cell-degranulating peptide from bee venom, polymyxin B, bradykinin and various synthetic poly(amino acids) and short-chain peptides. It was confirmed that a cluster of four basic residues (lysine or arginine) was optimal for histamine release by corticotropin and melittin polypeptides, provided that the C-terminal carboxyl group was substituted (by, for instance, amidation). In contrast, the presence of a free C-terminal carboxyl group or nearby dicarboxylic acid residues led to a considerable diminution in histamine-releasing activity. Likewise, polypeptides comprised essentially of acidic amino acids were inactive. On the basis of these observations it has been possible to predict that synthetic peptides comprising a particular sequence within the Fc region of human immunoglobulin E, the immunoglobulin class particularly involved in mediation of allergic reactions of the immediate type, would possess potent histamine-releasing activity when similarly made to react with normal rat mast cells. The further study of such a structure should throw new light on the molecular basis of allergen-antibody triggering of mast cells.

1960 ◽  
Vol 112 (4) ◽  
pp. 571-580 ◽  
Author(s):  
David Lagunoff ◽  
Earl P. Benditt

A method is described by which mast cells harvested from the rat peritoneal cavity can be deposited on the surface of a Millipore filter without gross injury, permitting observation of morphological and chemical changes induced by a variety of agents. These isolated peritoneal mast cells respond to 48/80 and to polymyxin B but not to dextran or ovomucoid with degranulation and histamine release. Thus four agents which in vivo appear to have similar activities have been found by means of in vitro analysis to operate by at least two different mechanisms.


2004 ◽  
Vol 13 (5-6) ◽  
pp. 365-368 ◽  
Author(s):  
Elzbieta Stankiewicz ◽  
Ewa Wypasek ◽  
Barbara Plytycz

BACKGROUND and aim: Morphine co-injection has anti-inflammatory effects on zymosan-induced peritonitis in several strains of mice except that of CBA. As peritoneal mast cells (pMCs) are much more numerous in CBA mice than in SWISS mice, the role of pMCs in morphine-modulated zymosan peritonitis is compared in CBA and SWISS males.Methods: pMCs were treatedin vitrowith morphine or C48/80 for comparison of histamine release.In vivoaccumulation of leukocytes and histamine in peritoneal exudate were recorded after intraperitoneal injection with morphine, zymosan, or zymosan plus morphine.Results and conclusion: Morphine induces histamine release by pMCs from CBA mice but not SWISS mice.In vivomorphine-induced peritonitis is stronger in CBA mice than SWISS mice. Corollary, morphine anti-inflammatory effects on zymosan peritonitis are reversed in CBA mice by its pro-inflammatory action through CBA pMCs.


1997 ◽  
Vol 25 (02) ◽  
pp. 163-167 ◽  
Author(s):  
Hyung Min Kim

This study was carried out to examine the effect of an aqueous extract from Siegesbeckia pubescens (Compositae) (SPAE) on immunoglobulin E (IgE)-mediated immediate hypersensitivity reaction. Forty-eight hours passive cutaneous anaphylaxis in rats was significantly inhibited by oral administration of SPAE (100 μg/g). It also inhibited histamine release from rat peritoneal mast cells induced by anti-dinitrophenyl (DNP)-IgE and DNP-human serum albumin. The data indicate that SPAE has antiallergic activity, and that its action may be due to inhibition of histamine release from mast cells.


1980 ◽  
Vol 191 (1) ◽  
pp. 233-237 ◽  
Author(s):  
P D Roy ◽  
D M Moran ◽  
V Bryant ◽  
R Stevenson ◽  
D R Stanworth

Previous studies on histamine release by corticotropin peptides and melittin peptides were extended, leading to the identification of a synthetic peptide intermediate, Lys(Z)-Arg(NO2)-Arg(NO2)OMe, (I) as an active non-cytolytic histamine releaser from rat mast cells. However, significant differences in the releasing capacity of optical isomers of this compound, and of Lys-Lys-Arg-ArgOMe [methyl ester of corticotropin-(15-18)-tetrapeptide; ‘basic core’] were observed, with the L-forms being markedly more active. A study of various analogues of the tripeptide compound (I) indicated that the structural basis for mast-cell triggering by such peptidic agents was highly specific. The relevance of these observations to the immunologically induced histamine-release processes is discussed.


1984 ◽  
Vol 32 (12) ◽  
pp. 5051-5054 ◽  
Author(s):  
MICHINORI KUBO ◽  
HIDEAKI MATSUDA ◽  
YOSHIYUKI KIMURA ◽  
HIROMICHI OKUDA ◽  
SHIGERU ARICHI

1998 ◽  
Vol 20 (2) ◽  
pp. 301
Author(s):  
G.M. De Plater ◽  
R.L. Martin ◽  
P.J. Milburn

In this study we investigated the possibility that the C-type natriuretic peptide from platypus venom (ONP-39) contributes to the acute effects of envenomation, which include oedema, pain and erythema. These effects may result from the release of auto pharmacological mediators from mast cells. Using an in vitro assay we have demonstrated that both ONP-39 and the endogenous C-type natriuretic peptide (CNP-22) release histamine from rat peritoneal mast cells, an effect similar to the structurally homologous atrial natriuretic peptide (ANP) (Opgenorth et al., 1990, Peptides 11(5):1003-7). Two synthetic peptides, ONP-39(1-17) and ONP-39(18-39), corresponding to the N- and C- termini respectively, are equipotent, suggesting that ONP-39 and other natriuretic peptides do not act through conventional ANP receptors on mast cells. The ability of ONP-39 to promote histamine release suggests that it may contribute to the acute symptoms of envenomation.


Sign in / Sign up

Export Citation Format

Share Document